Mergers & Acquisitions ·
Centessa shareholders approve Eli Lilly subsidiary's acquisition via Scheme of Arrangement with overwhelming support
CNTACentessa Pharmaceuticals plc
Centessa Pharmaceuticals plc shareholders approved the Scheme of Arrangement and Company Shareholder Resolution to facilitate the acquisition by LDH XV Corporation, a subsidiary of Eli Lilly and Company. The Scheme Proposal received 126,653,456 votes in favor and 23,007 against, meeting the required 75% value threshold. Centessa Pharmaceuticals plc is a biotechnology company focused on developing clinical-stage drug candidates.